Ironwood Pharmaceuticals, Inc. (IRWD) Profit Margins
Over the twelve months to 2026-06-30, Ironwood Pharmaceuticals, Inc. (IRWD) had operating margin 60.1%, net margin 33.4%, free cash flow margin 47.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRWDIronwood Pharmaceuticals, Inc.Follow IRWD — free
—
Price chart with a free account
- Market cap
- 571.7M
- P/E TTM
- 4.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 99.4% | 68.5% | 93.1% | 100.0% | 99.3% | 93.6% | 90.6% | 94.4% | 99.2% | — | — | — | 99.3% | 93.2% | — | |
| Operating margin | -100.4% | -48.4% | -1101.4% | -221.6% | -68.3% | -18.9% | -5.2% | -43.5% | 28.0% | 36.7% | 56.1% | 61.0% | -213.5% | 26.5% | 33.3% | 60.1% | |
| Net margin | -98.5% | -48.3% | -1192.3% | -248.1% | -95.4% | -29.8% | -39.2% | -81.5% | 5.0% | 27.3% | 127.7% | 42.6% | -226.4% | 0.3% | 8.1% | 33.4% | |
| FCF margin | -128.9% | -55.7% | -1236.6% | -208.2% | -74.2% | -11.0% | -34.7% | -20.5% | 0.8% | 42.9% | 63.2% | 66.6% | 41.4% | 29.4% | 42.9% | 47.7% |
USD billions · SEC XBRL
Ironwood Pharmaceuticals, Inc. — questions
- What is Ironwood Pharmaceuticals, Inc.'s operating margin?
- 60.1% over the twelve months to 2026-06-30.
- What is Ironwood Pharmaceuticals, Inc.'s net profit margin?
- 33.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Ironwood Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.